The FDA has identified concerns with compounded BPC-157, including possible immunogenicity risks, peptide-related impurities, and limited safety information for proposed routes of administration
The 5-minute injection adds no meaningful time to an existing appointment convenient same-visit add-on
In the STEP-1 trial of 1,961 adults (Wilding and colleagues, Once-Weekly Semaglutide in Adults with Overweight or Obesity, New England Journal of Medicine, 2021), participants on semaglutide 2.4 mg lost an average of 14.9 percent of their body weight at 68 weeks, compared to 2.4 percent on placebo
GLP-1 Weight Loss Injections: What Is the Difference
A lack of vitamin B12 is treated with methylcobalamin
Heres what our customers have to say about their experience working with us